Showing results (951-960 of 1,171) with videos related to

Sort By:
Pageof 118
Liver Cancer|August 20, 2021
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody CombinationsXiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, et al.
Nature Nanotechnology|July 23, 2021
Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasmaBo Ning, Zhen Huang, Brady M Youngquist, et al.
Oncotarget|September 18, 2014
Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic targetQiang Gao, Guang-Yang Yu, Jie-Yi Shi, et al.
Journal of Cancer|March 28, 2018
Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching AnalysisChen-Yang Tao, Wei-Ren Liu, Lei Jin, et al.
Cancer Immunology, Immunotherapy : CII|July 25, 2019
Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomyMeng-Xin Tian, Yu-Fu Zhou, Wei-Feng Qu, et al.
Cancer Research|June 20, 2012
CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinomaQiang Gao, Ying-Jun Zhao, Xiao-Ying Wang, et al.
Clinical and Molecular Hepatology|August 6, 2024
Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinomaYu-Hang Ye, Hao-Yang Xin, Jia-Li Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2025
CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy ResistanceTian He, Zi-Yi Wang, Bin Xu, et al.
Hepatology (Baltimore, Md.)|March 16, 2017
Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinomaYingyun Yang, Ye Zhou, Jin Hou, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathwayHai-Xiang Sun, Yang Xu, Xin-Rong Yang, et al.
Pageof 118